Supplier Research

NBTY Acquires Zila's Nutraceuticals Business Unit

September 1, 2006

NBTY Acquires Zila’s Nutraceuticals Business Unit
In June, Zila Inc., Phoenix, AZ, an­nounced that it was considering the divestiture of its nutraceutical business, so it could effectively focus more on its cancer detection business. Two months later, it was announced by the company that its nutraceuticals business unit would be acquired by NBTY, Bohemia, NY. According to Zila, NBTY will purchase the business unit for $40.5 million, with $37.5 million to be paid in cash at close in October and the remainder to be paid through an earn-out formula that is dependent upon future performance of the business. Zila is the manufacturer and marketer of Ester-C and Ester-E.

  • Skeleton Crew: Solutions for Bone Health

    Skeleton Crew: Solutions for Bone Health

    Lisa Schofield, Contributing Writer||March 1, 2017
    Products that can help aging populations stay active and independent will be in a strong market position.

  • Formulation Strategies for  Aging Consumers

    Formulation Strategies for Aging Consumers

    Stephen Tindal, Director, Science and Technology, Catalent Pharma Solutions||March 1, 2017
    Convenience, flavor and novel combinations of ingredients can help offer better product experiences.

  • Enzymes: Essential to Wellness

    Enzymes: Essential to Wellness

    Sean Moloughney, Editor||March 1, 2017
    Aiding digestion and helping the body absorb nutrients, enzymes play critical roles in nutrition.